Why the study?
Little was known about endothelial microvesicle levels in the coronary circulation of patients with acute coronary syndrome and stable coronary artery disease.
Are endothelial microvesicles (EMVs) elevated in the coronary and peripheral circulation of patients with ACS compared to stable CAD, and are they associated with central blood pressure?
Are endothelial microvesicles (EMVs) elevated in the coronary and peripheral circulation of patients with ACS compared to stable CAD, and are they associated with central blood pressure?
Endothelial microvesicles are elevated in the coronary circulation of patients with ACS and stable CAD and correlate with central blood pressure, suggesting they are markers of ongoing vascular damage.
Answers are grounded in this paper and cite their sources.
EMVs may mark acute endothelial injury in ACS; leaves open their biomarker utility pending prospective studies.
BACKGROUND: Endothelial microvesicles (EMVs) have emerged as markers of endothelial injury. However, little is known about their levels in the coronary circulation of acute coronary syndrome (ACS) and stable coronary artery disease (CAD). We hypothesized that ACS patients exhibit a more pronounced increase of EMVs both in the peripheral and coronary circulation when compared with CAD. We also investigated possible associations of EMVs with markers preclinical target organ damage. METHODS: We enrolled consecutive eligible patients undergoing coronary angiography. Blood samples were collected from the stem of the left coronary artery and the femoral artery. ΕMVs were measured by a standardized flow cytometry protocol. Central systolic blood pressure (cSBP) was measured invasively and patients' history was recorded. RESULTS: CAD patients exhibited increased levels of EMVs compared with controls. When patients with ACS and stable CAD were compared, the former had significantly increased EMVs in both coronary and peripheral circulation. Importantly, both ACS and CAD patients exhibited increased levels of EMVs in the coronary circulation compared with periphery. In addition, EMVs were associated with cSBP. CONCLUSIONS: EMVs emerge as novel markers of ongoing underlying vascular damage, further augmenting the vicious cycle of inflammation and thrombosis mainly in ACS but also in stable CAD.
No takes yet. Share an insight, caveat, or question.
Gkaliagkousi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: